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These cases illustrate the extreme and persistent toxicity associated with 
loperamide abuse and the need to treat ECG derangements aggressively, even 





A 39-year-old woman with Hepatitis C, depression and IVDA was transported 
to the ED after reported seizure-like activity. The patient experienced TdP in 
the ED and admitted to ingesting large amount of loperamide daily. An ECG 
demonstrated sinus rhythm 64 bpm, right axis deviation, PR interval 208ms, 
QRS interval 142ms and QTc 687 ms. She was administered IV magnesium, 
sodium bicarbonate, and later, isoproterenol. After ICU admission, the patient 
experienced no further TdP and was discharged on HD 6. Loperamide and 
desmethyl loperamide concentrations on HD 4 were undetectable and 27ng/
mL, respectively.
Figure 1. ED ECG#1, 28-year-old 
male.
Figure 6. ED ECG #1, 39-year-old female. Figure 7. ECG #2, 39-year-old female. 
Figure 2. ED ECG#2, 28-year-old 
male.
Figure 3. ED HD2, 28-year-old male.
Figure 4. ECG HD3 showing Torsades de Pointes.
Figure 5. EKG from HD4, associated with 
TdP episode requiring cardioversion.
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Loperamide (Imodium TM) is an 
antidiarrheal opioid acting at the µ 
receptor agonist in high concentrations. 
Due to the US opioid epidemic, loperamide 
abuse and ensuing life-threatening toxicity 
has surfaced.  
A 28-year-old man with a history of depression and heroin abuse presented to the ED 
with shortness of breath and lightheadedness. He admitted to ingesting large amounts of 
loperamide daily. His initial ECG demonstrated sinus rhythm 67 bpm, right axis deviation, 
undetectable PR interval, QRS 168ms and QTc 693ms. The patient was administered sodium 
bicarbonate and magnesium sulfate IV and admitted to the ICU. On HD 2, he developed 
persistent TdP. He was administered lidocaine and isoproterenol infusions, and a temporary, 
external pacemaker was placed for overdrive pacing. He was discharged in stable condition 
on HD 16 after all therapies were discontinued. Serum loperamide and desmethyl loperamide 
concentrations obtained on HD 1 measured 120ng/mL and 560ng/mL, respectively. Serum 
loperamide and desmethyl loperamide concentrations on HD 10 measured undetectable and 
16ng/mL, respectively.
The timing and duration of Torsades de 
Pointes (TdP) from loperamide toxicity is 
unpredictable and should be heeded with 
caution, even in asymptomatic patients 
and drug discontinuance.
HYPOTHESIS:
Two patients presenting with life-
threatening TdP requiring lengthy hospital 
admissions for confirmed loperamide 
toxicity are discussed. Patient data were 
retrieved from the hospital’s EMR system.
METHODS:
